We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-17.86%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.26B
AUM Growth
-$464M
Cap. Flow
+$97.5M
Cap. Flow %
4.32%
Top 10 Hldgs %
30.92%
Holding
158
New
12
Increased
35
Reduced
23
Closed
24

Top Buys

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$50.6M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$28.2M
3
ZGNX
Zogenix, Inc.
ZGNX
+$21.7M
4
TLND
Talend S.A. American Depositary Shares
TLND
+$18.7M
5
TWLO icon
Twilio
TWLO
+$17.9M

Top Sells

Rank Stock Value
1
ANAB icon
AnaptysBio
ANAB
+$26.2M
2
ECYT
Endocyte, Inc. Common Stock
ECYT
+$23.3M
3
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$19.7M
4
SLDB icon
Solid Biosciences
SLDB
+$18.9M
5
SNA icon
Snap-on
SNA
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 42.75%
2 Technology 23.08%
3 Consumer Discretionary 10.05%
4 Industrials 6.38%
5 Communication Services 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPLN
26
Openlane
OPLN
$4.29B
$29.1M 1.29%
1,611,620
– –
ROP icon
27
Roper Technologies
ROP
$38.5B
$28.3M 1.25%
106,000
+19,000
+22% +$5.37M
MGA icon
28
Magna International
MGA
$19B
$27.9M 1.23%
613,700
– –
ALTR
29
DELISTED
Altair Engineering Inc
ALTR
$27.6M 1.22%
1,000,000
– –
BLUE
30
DELISTED
bluebird bio
BLUE
$27.5M 1.22%
21,431
– –
WBC
31
DELISTED
WABCO HOLDINGS INC.
WBC
$27.4M 1.21%
255,600
– –
ASML icon
32
ASML
ASML
$634B
$26.9M 1.19%
173,000
+1,000
+0.6% +$170K
ARGX icon
33
argenx
ARGX
$54.6B
$24.4M 1.08%
254,000
-81,000
-24% -$7.2M
STLD icon
34
Steel Dynamics
STLD
$36.2B
$22.6M 1%
754,000
– –
LEA icon
35
Lear
LEA
$7.33B
$22.6M 1%
184,000
– –
BPMC
36
DELISTED
Blueprint Medicines
BPMC
$22.2M 0.98%
412,000
+130,000
+46% +$7.9M
MNTA
37
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$21.8M 0.96%
1,973,461
+1,248,461
+172% +$17.4M
QURE icon
38
uniQure
QURE
$2.93B
$21.2M 0.94%
736,209
+166,509
+29% +$4.63M
IMMU
39
DELISTED
Immunomedics Inc
IMMU
$20.1M 0.89%
1,412,000
+713,000
+102% +$14.2M
TWLO icon
40
Twilio
TWLO
$29B
$19.6M 0.87%
+220,000
New +$17.9M
MIC
41
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$19.6M 0.87%
536,000
-492,000
-48% -$19.7M
PEGI
42
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$19.5M 0.86%
1,045,000
-20,500
-2% -$398K
MTD icon
43
Mettler-Toledo International
MTD
$27.9B
$19.2M 0.85%
34,000
+5,000
+17% +$2.9M
BHVN
44
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$18.2M 0.81%
493,000
+199,000
+68% +$7.17M
IPHI
45
DELISTED
INPHI CORPORATION
IPHI
$17.8M 0.79%
555,000
– –
KALV
46
DELISTED
KalVista Pharmaceuticals
KALV
$17.8M 0.79%
900,000
– –
PAYC icon
47
Paycom
PAYC
$7.53B
$17.3M 0.76%
141,000
+45,000
+47% +$5.76M
AY
48
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$17M 0.75%
866,000
– –
ICPT
49
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$16.9M 0.75%
+168,000
New +$17.4M
APTV icon
50
Aptiv
APTV
$12.3B
$16.9M 0.75%
274,350
+4,750
+2% +$344K
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Eventide Asset Management held 158 positions worth $2.26B, down 17% from $2.72B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Eventide Asset Management deployed $97.5M of net new capital in Q4 2018, opening 12 new positions and adding to 35 existing holdings. Its largest new stake was Talend S.A. American Depositary Shares: 388,033 shares worth $14.4M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Macquarie Infrastructure Holdings, LLC, an estimated $19.7M trimmed.

  • Eventide Asset Management's largest Q4 2018 buy was Talend S.A. American Depositary Shares: 388,033 shares worth $14.4M.
  • Eventide Asset Management added most to Sage Therapeutics in Q4 2018, an estimated $50.6M increase.
  • Eventide Asset Management's biggest Q4 2018 reduction was Macquarie Infrastructure Holdings, LLC, cutting an estimated $19.7M.
  • Eventide Asset Management fully exited AnaptysBio in Q4 2018, selling an estimated $26.2M.
  • Eventide Asset Management's ten largest holdings make up 31% of its $2.26B portfolio in Q4 2018.
  • Eventide Asset Management opened 12 new positions and closed 24 in Q4 2018.
  • Eventide Asset Management's portfolio value fell 17% quarter-over-quarter to $2.26B.

Based on Eventide Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.